stars 1 stars 2 stars 3

LCM Genect is an Italian company committed to the trade of new tests for molecular diagnosis pharmacogenetics and Point Of Care. Our goal is to provide Precision and Preventive Medicine to all patients earlier, by delivering technological innovation as well as reliable tests, so that their outcomes may be used to personalize therapy protocols, bringing tangible benefits to everyone. LCM Genect is part of the LCM Group, which is specialized in the supply chain of chemicals, especially APIs for the pharmaceutical industry. The focus of our entire Group is therefore on health and wellbeing. In our vision, molecular diagnosis, pharmacogenetics and Point Of Care can become an opportunity for everyone’s life. Our values Scientificity, Innovation, Knowledge and Tradition are values that lead us and on which we based our commitment. Our mission Our solid roots in pharmaceutical field allow us to face new challenges to provide innovative genetic tests and diagnostic tests to find customized and rapid solutions for each patient.

LCM Genect Questions

The LCM Genect annual revenue was $202000 in 2026.

Enabling Medicine is the Executive Director of LCM Genect.

1 people are employed at LCM Genect.

LCM Genect is based in Sesto San Giovanni, Lombardy.

The NAICS codes for LCM Genect are [541, 5417, 541713, 54171, 54].

The SIC codes for LCM Genect are [873, 87].

Top LCM Genect Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users